May 6, 2020
Fitbit announced this morning the launch of a new atrial fibrillation research study aiming to enroll hundreds of thousands of fitness-tracker and smartwatch owners.
Called the Fitbit Heart Study, it will passively and continuously monitor wearers' heart rates using the devices' photoplethysmography (PPG) sensors. A proprietary algorithm will interpret these readings and flag potential...
January 22, 2020
Editor's note: This story has been updated with information from Verily's announcement of the clearance.
Verily, the life sciences research subsidiary of Alphabet, has received FDA 510(k) clearance for an augmented version of its prescription Study Watch wearable that includes some form of arrhythmia monitoring.
The Study Watch With Irregular Pulse Monitor is classified by the FDA as a “...
March 16, 2016
Lowell, Massachusetts-based InfoBionic has received FDA 510(k) clearance for its remote patient monitoring system, MoMe Kardia, not to be confused with AliveCor’s recently product portfolio rebrand, which is also now named Kardia.
The MoMe Kardia is designed to help detect cardiac arrhythmias in patients by sensing ECG, respiration, and motion. The lightweight monitoring device can be worn as a...
November 18, 2015
iRhythm Technologies, maker of the Zio peel-and-stick wearable heart monitor, has launched a patient-facing companion app on iOS, called myZio, as well as a website, called myZio.com. The app and website allow wearers to track additional health data. They don't display data collected by the Zio patch.
These are the first patient-facing data offerings that the company, which commercially launched...
November 24, 2014
Lowell, Massachusetts-based remote patient monitoring company InfoBionic raised $17 million in a round led by Safeguard Scientifics, which now owns 20 percent of the company. Other investors that participated in the round include Excel Venture Management, Zaffre Investments and existing investors Mass Medical Angels (MA2), Broadview Ventures, TiE, Beta Fund, Boardwalk, Launchpad Venture Group,...
November 29, 2012
This week Conshohocken, PA-based wireless cardiac monitoring company CardioNet announced the launch of an iPad app, called CardioNet Access. The app is for physicians who prescribe the company's mobile cardiac outpatient telemetry (MCOT) system, which helps doctors diagnose and monitor cardiac arrhythmias. The CardioNet Access app offers its physician users "easier accessibility to their patient...
November 20, 2012
The MCOTos, released earlier this year.
CardioNet, one of the oldest companies in the mobile cardiac arrhythmia monitoring space, announced the launch of a new product last week, the wEvent wireless event monitor.
"This new wireless device provides physicians a much improved replacement to their traditional event monitor," CEO Joseph Capper said in a statement. "The wEvent, unlike existing event...
September 11, 2012
Minneapolis-based Preventice announced this week that the FDA had cleared its remote monitoring device for patients with cardiac arrhythmias, the BodyGuardian Remote Monitoring System, with a 510(k) clearance. Preventice developed the system with its partner Mayo Clinic and licensed technology from Proteus Biomedical's partner Avery Dennison for the peel-and-stick sensor.
BodyGuardian is a small...